— Shares of Dollar Tree popped more than 3% after the discount retailer reiterated its fiscal second-quarter 2023 earnings guidance. The company expected quarterly earnings between 79 cents per share and 89 cents per share. It also maintained its full-year outlook for the fiscal year.
— The Netherlands-based gene therapy stock dropped 38.7% after the company gave an update on a late-stage trial for a potential therapy for Huntington's Disease. On Tuesday, the company said it hit a $100 million milestone related to its first commercial sale of Hemgenix, which is used in the treatment of adults with hemophilia B.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: MarketWatch - 🏆 3. / 97 Lire la suite »
La source: Reuters - 🏆 2. / 97 Lire la suite »
La source: CNBC - 🏆 12. / 72 Lire la suite »